A small-scale Japanese study focusing on cell injection therapy to treat pseudophakic endothelial failure has reported the restoration of normal function in 91% of eyes, five years
Targeted cancer therapy (TCT) has the potential to cause ocular toxicity, reported researchers in Ophthalmology Times. “TCT is a major advance in oncology and has significant survival benefits for
The phase 2b trial of jCyte’s jCell has shown that the minimally invasive intravitreal injection therapy for retinitis pigmentosa (RP) significantly improved patients’ best corrected visual
A Spanish study that compared different designs of toric silicone-hydrogel contact lenses (CLs) has shown significant variations in performance.
Made possible with support from Blind Low Vision NZ (BLVNZ), this year’s Low Vision Day at Auckland University was an amazing opportunity for BOptom students like us to interact directly with low vision patients and specialists. Throughout the day, not only were our clinical skills put to the test b
In phase 2 trials Aura Biosciences’ virus-like drug conjugate (VDC) infrared light-activated AU-011 therapy successfully bound to and killed tumour cells.
Six months after being named as winners of the Spark 5G Starter Fund, Objective Acuity and oDocs Eye Care were invited to Spark’s Auckland headquarters to offer media a first glimpse of the positive outcomes 5G can bring to eye health in New Zealand.
oDocs showcased its teleophthalmology platform and portable handheld fundus camera at the New Zealand Trade & Enterprise pre-World Expo in Auckland in the lead up to the 2020 Dubai World Expo. Delayed due to the pandemic the World Expo will now run from October 2021 to 31 March 2022.
A study of more than 900,000 eyes has shown that patients who have undergone intravitreal therapy prior to cataract surgery have greater risk of intraoperative complications (IC).
The International Myopia Institute (IMI) has released a second set of myopia white papers to support continued education, research and management of myopia to help combat the growing myopia epidemic.
The government’s recent announcement of a major restructure that will see the 20 district health boards replaced by one new body, Health New Zealand, has been cautiously welcomed by the country’s eyecare professionals (ECPs).